Revisiting History of Treatment of Attention Deficit Hyperactivity Disorder : Pharmacologic Approach.
- Author:
Geon Ho BAHN
1
;
Minha HONG
;
Yeon Jung LEE
;
Ju Hee HAN
;
Soo Hyun OH
Author Information
1. Department of Psychiatry, School of Medicine, Kyung Hee University, Seoul, Korea. mompeian@khu.ac.kr
- Publication Type:Review
- Keywords:
ADHD;
History;
Medication;
Amphetamine;
Methylphenidate;
Atomoxetine
- MeSH:
Adult;
Amphetamine;
Atomoxetine Hydrochloride;
Attention Deficit Disorder with Hyperactivity*;
Brain;
Central Nervous System Stimulants;
Child;
Encephalitis;
Humans;
Mental Disorders;
Methylphenidate;
Philosophy;
Survivors
- From:Journal of the Korean Society of Biological Psychiatry
2014;21(2):37-48
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Besides from medical data, the patients who were previously called as attention disorder, mental instability, moral imbeciles, or moral defectives, can also be identified by exploring literatures and historical figures. In the past, as we can notice from the titles, they were recognized as a 'moral defect group'. And rather than treating them, separation from the society was the main solution. After the endemic encephalitis from 1917 to late 1920s, however, many survivors suffered from behavioral problems similar to those of the previous 'moral defect group' and studies on the relationship between brain damage and behavior problems were started henceforth. After being known as the 'minimal brain dysfunction', it was developed into the current attention-deficit/hyperactivity disorder. While the disease concept changed and developed over time, after numerous trials and errors, treatment medication starting from central nervous system stimulants such as amphetamine and methylphenidate is used for treatment in children and adult patients with ADHD, and most recently non-stimulants such as atomoxetine has become the one of the first line treatment options. Although we went through a thorough verification process of the safety and efficacy of the medication by contemplating the historical development process, we believe that adjustment is needed for remaining concerns on medication abuse and slight differences in disease paradigm and therapeutic philosophy depending on cultures.
